Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Carna Biosciences Inc to Fully Acquire ProbeX Inc.


Wednesday, 4 Sep 2013 02:30am EDT 

Carna Biosciences Inc announced that it will fully acquire ProbeX Inc., a Tokyo-based company engaged in the planning, development, production, sale and consulting of probe reagent, cells and animal, through a stock swap effective October 1, 2013. 

Company Quote

856.0
30.0 +3.63%
23 Jul 2014